Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

被引：0
|
作者：
A. Afshar-Oromieh
A. Malcher
M. Eder
M. Eisenhut
H. G. Linhart
B. A. Hadaschik
T. Holland-Letz
F. L. Giesel
C. Kratochwil
S. Haufe
U. Haberkorn
C. M. Zechmann
机构：
[1] University Hospital of Heidelberg,Department of Nuclear Medicine
[2] German Cancer Research Center,Department of Radiopharmaceutical Chemistry
[3] National Center for Tumor Diseases (NCT)/DKFZ,Department of Urology
[4] University Hospital of Heidelberg,Department of Biostatistics
[5] German Cancer Research Center,Clinical Cooperation Unit Nuclear Medicine
[6] German Cancer Research Centre,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2013年 / 40卷
关键词：
Prostate Cancer; Positron Emission Tomography; Salivary Gland; Positron Emission Tomography Imaging; Prostate Tissue;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：971 / 972
页数：1
相关论文
共 50 条
  • [31] Precision imaging in the management of recurrent prostate cancer by targeted [68-Ga] Gallium-labelled prostate specific membrane antigen binding ligand positron emission tomography/magnetic resonance imaging (PSMA PET/MRI) in men with biochemical recurrence
    Joshi, A.
    Nicholson, C.
    Rhee, H.
    Mckenzie, I.
    Munns, J.
    Malone, G.
    Chung, E.
    Heathcote, P.
    Preston, J.
    Lawson, M.
    Gustafson, S.
    Wood, S.
    Miles, K.
    Vela, I.
    BJU INTERNATIONAL, 2017, 119 : 67 - 68
  • [32] Effect of furosemide on the bladder quantitative parameters in patients undergoing Gallium-68[68Ga] Ga-PSMA-11 PET/CT for diagnosis of prostate cancer
    Valenzuela, D.
    Tormo-Ratera, M.
    Papa, N.
    Eapen, R.
    Emmett, L.
    Moon, D.
    Murphy, D.
    Ayati, N.
    Hofman, M.
    Buteau, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S544 - S544
  • [33] [68Ga]PSMA-11 for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer
    Clore, Jessica
    Scott, Peter J. H.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024,
  • [34] Comparison of PET imaging with a 68Ga-labelled PSMA ligand versus 18F-choline PET/CT for the diagnosis of Prostate Cancer & Radioprotection for involved personnel
    Zeinab Khansa
    Mohamad B. Haidar
    Nemer Neaimeh
    Mahmoud Korek
    Health and Technology, 2019, 9 : 607 - 613
  • [35] Comparison of PET imaging with a 68Ga-labelled PSMA ligand versus 18F-choline PET/CT for the diagnosis of Prostate Cancer & Radioprotection for involved personnel
    Khansa, Zeinab
    Haidar, Mohamad B.
    Neaimeh, Nemer
    Korek, Mahmoud
    HEALTH AND TECHNOLOGY, 2019, 9 (04) : 607 - 613
  • [36] PET imaging with 68Gallium-labelled ligand of prostate-specific membrane antigen (68Ga-HBED-PSMA) for staging of biochemical recurrent prostate cancer after radical prostatectomy.
    Maurer, Tobias
    Gschwend, Juergen
    Wester, Hans-Juergen
    Souvatzoglou, Michael
    Beer, Ambros
    Holzapfel, Konstantin
    Weirich, Gregor
    Haller, Bernhard
    Kuebler, Hubert
    Schwaiger, Markus
    Eiber, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience
    A. Afshar-Oromieh
    U. Haberkorn
    H. P. Schlemmer
    M. Fenchel
    M. Eder
    M. Eisenhut
    B. A. Hadaschik
    A. Kopp-Schneider
    M. Röthke
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 887 - 897
  • [38] Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience
    Afshar-Oromieh, A.
    Haberkorn, U.
    Schlemmer, H. P.
    Fenchel, M.
    Eder, M.
    Eisenhut, M.
    Hadaschik, B. A.
    Kopp-Schneider, A.
    Roethke, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 887 - 897
  • [39] Biodistribution of Ga-68 labelled Prostate Specific Membrane Antigen Ligand Glu-NH-CO-NH-Lys-(Ahx)-[68Ga (HBED-CC)] in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions
    Kulkarni, H. R.
    Baum, R. P.
    Wester, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S412 - S412
  • [40] A Novel Gallium-68-Labelled GRP Receptor Antagonist, [68Ga]Sarabesin 3, for Prostate Cancer Imaging: First Results in Therapy Naive Primary Patients
    Bakker, I. L.
    Froberg, A. C.
    Busstra, M.
    van Leenders, G. J. L. H.
    de Blois, E.
    Schoots, I.
    Veenland, J.
    Maina, T.
    van Weerden, W. M.
    Nock, B.
    de Jong, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S125 - S125
12345